These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
764 related items for PubMed ID: 19168260
21. Stereotactic body radiation therapy using three fractions for isolated lung recurrence from colorectal cancer. Kim MS, Yoo SY, Cho CK, Yoo HJ, Choi CW, Seo YS, Kang JK, Lee DH, Hwang DY, Moon SM, Kim MS, Kang HJ, Kim YH. Oncology; 2009; 76(3):212-9. PubMed ID: 19218825 [Abstract] [Full Text] [Related]
23. Stereotactic hypofractionated radiotherapy in stage I (T1-2 N0 M0) non-small-cell lung cancer (NSCLC). Zimmermann FB, Geinitz H, Schill S, Thamm R, Nieder C, Schratzenstaller U, Molls M. Acta Oncol; 2006; 45(7):796-801. PubMed ID: 16982542 [Abstract] [Full Text] [Related]
24. Central thoracic lesions treated with hypofractionated stereotactic body radiotherapy. Milano MT, Chen Y, Katz AW, Philip A, Schell MC, Okunieff P. Radiother Oncol; 2009 Jun; 91(3):301-6. PubMed ID: 19329210 [Abstract] [Full Text] [Related]
26. Clinical outcomes of a phase I/II study of 48 Gy of stereotactic body radiotherapy in 4 fractions for primary lung cancer using a stereotactic body frame. Nagata Y, Takayama K, Matsuo Y, Norihisa Y, Mizowaki T, Sakamoto T, Sakamoto M, Mitsumori M, Shibuya K, Araki N, Yano S, Hiraoka M. Int J Radiat Oncol Biol Phys; 2005 Dec 01; 63(5):1427-31. PubMed ID: 16169670 [Abstract] [Full Text] [Related]
28. Stereotactic single-dose radiotherapy (radiosurgery) of early stage nonsmall-cell lung cancer (NSCLC). Hof H, Muenter M, Oetzel D, Hoess A, Debus J, Herfarth K. Cancer; 2007 Jul 01; 110(1):148-55. PubMed ID: 17516437 [Abstract] [Full Text] [Related]
29. Local control of metastatic lung tumors treated with SBRT of 48 Gy in four fractions: in comparison with primary lung cancer. Hamamoto Y, Kataoka M, Yamashita M, Shinkai T, Kubo Y, Sugawara Y, Inoue T, Sakai S, Aono S, Takahashi T, Semba T, Uwatsu K. Jpn J Clin Oncol; 2010 Feb 01; 40(2):125-9. PubMed ID: 19825814 [Abstract] [Full Text] [Related]
31. Stereotactic body radiotherapy for medically inoperable patients with stage I non-small cell lung cancer - a first report of toxicity related to COPD/CVD in a non-randomized prospective phase II study. Baumann P, Nyman J, Hoyer M, Gagliardi G, Lax I, Wennberg B, Drugge N, Ekberg L, Friesland S, Johansson KA, Lund JS, Morhed E, Nilsson K, Levin N, Paludan M, Sederholm C, Traberg A, Wittgren L, Lewensohn R. Radiother Oncol; 2008 Sep 01; 88(3):359-67. PubMed ID: 18768228 [Abstract] [Full Text] [Related]
32. Aggravation of dyspnea in stage I non-small cell lung cancer patients following stereotactic body radiotherapy: Is there a dose-volume dependency? Paludan M, Traberg Hansen A, Petersen J, Grau C, Høyer M. Acta Oncol; 2006 Sep 01; 45(7):818-22. PubMed ID: 16982545 [Abstract] [Full Text] [Related]
34. Application of robotic stereotactic radiotherapy to peripheral stage I non-small cell lung cancer with curative intent. Brown WT, Wu X, Fayad F, Fowler JF, García S, Monterroso MI, de la Zerda A, Schwade JG. Clin Oncol (R Coll Radiol); 2009 Oct 01; 21(8):623-31. PubMed ID: 19682875 [Abstract] [Full Text] [Related]
37. Stereotactic body radiotherapy for oligometastatic lung tumors. Norihisa Y, Nagata Y, Takayama K, Matsuo Y, Sakamoto T, Sakamoto M, Mizowaki T, Yano S, Hiraoka M. Int J Radiat Oncol Biol Phys; 2008 Oct 01; 72(2):398-403. PubMed ID: 18374506 [Abstract] [Full Text] [Related]